HIV/AIDS Clinical Trials in New York

Showing 201-220 of 342 trials

Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS

NCT00079560

Smoked marijuana (MJ) and dronabinol (also known as THC or by the trade name Marinol) are used to increase appetite, food intake, and weight in patients with HIV who experience unintended weight loss. This study will compare the effects of MJ and Marinol use in marijuana smokers who are HIV infected.

HIV Infections

National Institute on Drug Abuse (NIDA)30 participantsStarted Dec 2001

New York, New York, United States

COMPLETEDPHASE2< 1 mile

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

NCT00201123

This study will evaluate the lung's immune response to mycobacterium tuberculosis (Mtb) infection and will modulate that response with interferon-gamma.

TuberculosisAIDS-related Complex

NYU Langone Health89 participantsStarted Apr 2005

New York, New York, United States • Cape Town, South Africa

APPROVED_FOR_MARKETING< 1 mile

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

NCT00097799

This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.

HIV Infections

Boehringer IngelheimStarted Dec 2004

Anniston, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +112 more locations

Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

HIV/AIDS Trials in Other Cities

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

CSP #512 - Options in Management With Anti-Retrovirals

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

Optimal Treatment for Kidney Disease in HIV Infected Adults

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Other Conditions in New York